HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic… Grant US-11813261-B2 United States of America 14 Nov 2023
Use of inhibitors of Brutons tyrosine kinase (Btk) Grant US-11672803-B2 United States of America 13 Jun 2023
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or… Grant US-11654143-B2 United States of America 23 May 2023
Certain chemical entities, compositions and methods Grant US-11433065-B2 United States of America 06 Sep 2022
Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one Grant US-11312718-B2 United States of America 26 Apr 2022
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or… Grant US-11166951-B2 United States of America 09 Nov 2021
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen… Grant US-11149076-B2 United States of America 19 Oct 2021
Imidazopyrazine inhibitors of Bruton's tyrosine kinase Grant US-11110088-B2 United States of America 07 Sep 2021
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10961251-B1 United States of America 30 Mar 2021
Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK) Grant US-10954567-B2 United States of America 23 Mar 2021
Treatment of cancer using humanized anti-CD19 chimeric antigen receptor Grant US-10927184-B2 United States of America 23 Feb 2021
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor Grant US-10828259-B2 United States of America 10 Nov 2020
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant US-10751342-B2 United States of America 25 Aug 2020
Crystalline forms of a brutons tyrosine kinase inhibitor Grant US-10752634-B2 United States of America 25 Aug 2020
Imidazopyrazine inhibitors of Bruton's tyrosine kinase Grant US-10736893-B2 United States of America 11 Aug 2020
Use of inhibitors of bruton's tyrosine kinase (BTK) Grant US-10653696-B2 United States of America 19 May 2020
Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one… Grant US-10550122-B2 United States of America 04 Feb 2020
Use of inhibitors of bruton's tyrosine kinase (Btk) Grant US-10478439-B2 United States of America 19 Nov 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10294232-B2 United States of America 21 May 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10294231-B2 United States of America 21 May 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10266540-B2 United States of America 23 Apr 2019
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor Grant US-10213386-B2 United States of America 26 Feb 2019
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant US-10125140-B1 United States of America 13 Nov 2018
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10106548-B2 United States of America 23 Oct 2018
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant US-10065968-B2 United States of America 04 Sep 2018
Carbazole and tetrahydrocarbazole compounds useful as inhibitors of BTK Grant US-10023534-B2 United States of America 17 Jul 2018
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant US-10016435-B2 United States of America 10 Jul 2018
Methods for the treatment of HER2 amplified cancer Grant US-10016434-B2 United States of America 10 Jul 2018
Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor Grant US-10010507-B1 United States of America 03 Jul 2018
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant US-10004746-B2 United States of America 26 Jun 2018
Use of inhibitors of Bruton'S tyrosine kinase (Btk) Grant US-10004745-B2 United States of America 26 Jun 2018
Inhibition of Bruton's tyrosine kinase (Btk) in the lung to treat severe lung… Application US-9982265-B2 United States of America 29 May 2018
Phospholipase C gamma 2 and resistance associated mutations Grant US-9885086-B2 United States of America 06 Feb 2018
Novel Formulations of a Bruton's Tyrosine Kinase Inhibitor Application US-20180028537-A1 United States of America 01 Feb 2018
Solid forms of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1 (2H)-one… Grant US-9840505-B2 United States of America 12 Dec 2017
Processes for preparing isoquinolinones and solid forms of isoquinolinones Grant US-RE46621-E1 United States of America 05 Dec 2017
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant US-9828383-B1 United States of America 28 Nov 2017
Certain chemical entities, compositions and methods Grant US-9822131-B2 United States of America 21 Nov 2017
Use of inhibitors of bruton'S tyrosine kinase (BTK) Grant US-9814721-B2 United States of America 14 Nov 2017
Use of inhibitors of bruton's tyrosine kinase (Btk) Grant US-9801883-B2 United States of America 31 Oct 2017
Use of inhibitors of bruton's tyrosine kinase (BTK) Grant US-9801881-B2 United States of America 31 Oct 2017
Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors Grant US-9795605-B2 United States of America 24 Oct 2017
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant US-9725455-B1 United States of America 08 Aug 2017
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-9713617-B2 United States of America 25 Jul 2017
THERAPEUTIC COMBINATIONS OF AN ANTIFOLATE AND A BTK INHIBITOR Application WO-2017122175-A1 World Intellectual Property Organisation (WIPO) 20 Jul 2017
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor Grant US-9655857-B2 United States of America 23 May 2017
Certain chemical entities, compositions and methods Grant US-9655892-B2 United States of America 23 May 2017
IMIDAZOPYRAZINE INHIBITORS OF BRUTON'S TYROSINE KINASE Application WO-2017077507-A1 World Intellectual Property Organisation (WIPO) 11 May 2017
THERAPEUTIC COMBINATIONS OF A CD19 INHIBITOR AND A BTK INHIBITOR Application WO-2017046747-A1 World Intellectual Property Organisation (WIPO) 23 Mar 2017
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR AND A GITR BINDING MOLECULE, A 4-1BB AGONIST… Application WO-2017046746-A1 World Intellectual Property Organisation (WIPO) 23 Mar 2017
THERAPEUTIC COMBINATIONS OF A MEK INHIBITOR AND A BTK INHIBITOR Application WO-2017033113-A1 World Intellectual Property Organisation (WIPO) 02 Mar 2017
4-AMINO-6-(2,6-DICHLOROPHENYL)-8-METHYL-2-(PHENYLAMINO)-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE… Application WO-2017013160-A1 World Intellectual Property Organisation (WIPO) 26 Jan 2017
Pyrazolo[3,4-d]pyrimidine and pyrazolo[2,3-d]pyrimidine compounds as kinase inhibitors Grant US-9546172-B2 United States of America 17 Jan 2017
Pyrrolopyrimidine compounds as kinase inhibitors Grant US-9540385-B2 United States of America 10 Jan 2017
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-9540382-B2 United States of America 10 Jan 2017
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders… Grant US-9527847-B2 United States of America 27 Dec 2016
Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof Grant US-9522146-B2 United States of America 20 Dec 2016
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PI3K INHIBITOR, A JAK-2 INHIBITOR, A PD-1… Application WO-2016128912-A1 World Intellectual Property Organisation (WIPO) 18 Aug 2016
COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL… Application WO-2016116777-A1 World Intellectual Property Organisation (WIPO) 28 Jul 2016
BTK INHIBITORS TO TREAT SOLID TUMORS THROUGH MODULATION OF THE TUMOR MICROENVIRONMENT Application WO-2016087994-A1 World Intellectual Property Organisation (WIPO) 09 Jun 2016
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-9296753-B2 United States of America 29 Mar 2016
Processes for preparing isoquinolinones and solid forms of isoquinolinones Grant US-9290497-B2 United States of America 22 Mar 2016
Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors Grant US-9278100-B2 United States of America 08 Mar 2016
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PI3K INHIBITOR, A JAK-2 INHIBITOR, AND/OR… Application WO-2016024230-A1 World Intellectual Property Organisation (WIPO) 18 Feb 2016
BTK INHIBITORS TO TREAT SOLID TUMORS THROUGH MODULATION OF THE TUMOR MICROENVIRONMENT Application WO-2016024227-A1 World Intellectual Property Organisation (WIPO) 18 Feb 2016
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PI3K INHIBITOR, A JAK-2 INHIBITOR, A PD-1… Application WO-2016024231-A1 World Intellectual Property Organisation (WIPO) 18 Feb 2016
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PI3K INHIBITOR, A JAK-2 INHIBITOR AND/OR A… Application WO-2016024232-A1 World Intellectual Property Organisation (WIPO) 18 Feb 2016
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PI3K INHIBITOR, A JAK-2 INHIBITOR, A PD-1… Application WO-2016024228-A1 World Intellectual Property Organisation (WIPO) 18 Feb 2016
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PI3K INHIBITOR AND/OR A JAK-2 INHIBITOR Application WO-2015193740-A2 World Intellectual Property Organisation (WIPO) 23 Dec 2015
Certain chemical entities, compositions and methods Grant US-9216982-B2 United States of America 22 Dec 2015
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof Grant US-9206182-B2 United States of America 08 Dec 2015
METHODS OF TREATING CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LEUKEMIA USNG A… Application WO-2015110923-A2 World Intellectual Property Organisation (WIPO) 30 Jul 2015